These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33169334)

  • 21. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
    Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
    Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.
    Smeets SJ; Hesselink AT; Speel EJ; Haesevoets A; Snijders PJ; Pawlita M; Meijer CJ; Braakhuis BJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2007 Dec; 121(11):2465-72. PubMed ID: 17680565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
    Ribeiro EA; Maleki Z
    J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
    Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
    Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
    Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The distribution of human papillomavirus in tissues from patients with head and neck squamous cell carcinoma.
    Wei W; Shi Q; Guo F; Zhang BY; Chen C; Zhang NS; Dong XP
    Oncol Rep; 2012 Nov; 28(5):1750-6. PubMed ID: 22923266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran.
    Farhadi A; Abuei H; Okhovat MA; Geramizadeh B; Behzad-Behbahani A; Chong PP; Nikouyan N; Namdari S
    Cancer Cell Int; 2023 Aug; 23(1):166. PubMed ID: 37568237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.
    Weiss D; Koopmann M; Rudack C
    Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
    Omran OM; AlSheeha M
    Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients.
    Molimard C; L'Huillier V; Overs A; Soret C; Algros MP; Mougin C; Guenat D; Mauvais O; Prétet JL
    J Int Med Res; 2021 Jul; 49(7):3000605211022534. PubMed ID: 34232797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
    Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
    Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.
    Guo M; Khanna A; Dhillon J; Patel SJ; Feng J; Williams MD; Bell DM; Gong Y; Katz RL; Sturgis EM; Staerkel GA
    Cancer Cytopathol; 2014 Feb; 122(2):96-103. PubMed ID: 24339259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.